AMSilk | Jotup

EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Retrieved on:

Wednesday, March 13, 2024

AMSilk, Protein engineering, A-DNA, AI, Research and development, Molecular biology, PCT, Gold, Gel, Microplastics, CO2, BRAIN, Partnership, Fine chemical

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Key Points:

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
The issuer is solely responsible for the content of this announcement.
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
Zwingenberg / Neuried (Germany), March 5, 2024 - BRAIN Biotech AG, leading provider of solutions for the biologization of industry, and AMSilk GmbH, a global leader in advanced materials made from spider silk-based proteins, announce the successful completion of the first phase of a development collaboration.
The success of this strategic R&D collaboration is based on the use of BRAIN Biotech’s rational design in protein engineering.
With their years of protein engineering expertise and with our common vision, BRAIN Biotech is an ideal fit as a development partner.”

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Retrieved on:

Tuesday, March 5, 2024

AMSilk, A-DNA, AI, Research and development, Molecular biology, PCT, Patent Cooperation Treaty, Protein engineering, Gold, Gel, Microplastics, CO2, BRAIN, Partnership, Fine chemical

The success of this strategic R&D collaboration is based on the use of BRAIN Biotech's rational design in protein engineering.

Key Points:

The success of this strategic R&D collaboration is based on the use of BRAIN Biotech's rational design in protein engineering.
BRAIN Biotech had already successfully used its protein engineering strategy in the development of a variety of protein and enzyme products in order to tailor them for industrial applications.
Pelzer cites powerful bioinformatics including the various AI approaches used by the experienced protein engineering experts at BRAIN Biotech as the basis for protein engineering, tailoring their approach to each specific inquiry.
With their years of protein engineering expertise and with our common vision, BRAIN Biotech is an ideal fit as a development partner."

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

Retrieved on:

Tuesday, March 5, 2024

AMSilk, A-DNA, AI, Research and development, Molecular biology, PCT, Patent Cooperation Treaty, Protein engineering, Gold, Gel, Microplastics, CO2, BRAIN, Partnership, Fine chemical

The success of this strategic R&D collaboration is based on the use of BRAIN Biotech's rational design in protein engineering.

Key Points:

The success of this strategic R&D collaboration is based on the use of BRAIN Biotech's rational design in protein engineering.
BRAIN Biotech had already successfully used its protein engineering strategy in the development of a variety of protein and enzyme products in order to tailor them for industrial applications.
Pelzer cites powerful bioinformatics including the various AI approaches used by the experienced protein engineering experts at BRAIN Biotech as the basis for protein engineering, tailoring their approach to each specific inquiry.
With their years of protein engineering expertise and with our common vision, BRAIN Biotech is an ideal fit as a development partner."

EQS-News: MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024

Retrieved on:

Thursday, February 15, 2024

MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024

Key Points:

MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024
The issuer is solely responsible for the content of this announcement.
MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024
MIG Capital added three start-ups to its portfolio with talpasolutions, mbiomics and Look Up Space
In 2024, MIG Capital will continue its long-standing success with a focus on continued investment in highly innovative start-ups, the identification of exit options and continued expansion of the investment team
MIG Capital, one of Germany’s leading venture capital investors, reports a successful 2023 financial year.
Michael Motschmann, Managing Partner of MIG Capital, said: “For the entire VC sector, including ourselves, 2023 was the second difficult year in a row.
Dr. Matthias Kromayer, Managing Partner of MIG Capital, said: “Despite continued economic uncertainty, we see our portfolio companies making stable progress in 2024.

AMSilk and 21st.BIO announce partnership to accelerate the production of advanced materials made from spider silk-based proteins

Retrieved on:

Wednesday, January 17, 2024

CO2, BIO, Mercedes-Benz, Partnership, Car, Fermentation, Gel, Water, Protein, AMSilk, Silk

NEURIED, Germany and COPENHAGEN, Denmark, Jan. 17, 2024 /PRNewswire/ -- AMSilk, a global leader in advanced materials made from spider silk-based proteins, and 21st.BIO, a leader in bioproduction, today announced that they have joined forces to accelerate the upscaling of AMSilk's silk protein production to unprecedented levels. As part of the partnership, 21st.BIO has developed a new protein production strain created from highly specialized precision fermented microorganisms, ensuring that AMSilk can meet demand as it increases production from the laboratory to industrial scale.

Key Points:

Due to its unique combination of strength and flexibility, spider silk is the gold standard of bio industrial materials.
With a strong patent portfolio, AMSilk is leading the discovery of performance materials based on spider silk proteins.
Gudrun Vogtentanz, Chief Scientific Officer, AMSilk said: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
With spider silk proteins this has been challenging, but AMSilk is the first to be able to achieve that goal and bring spider silk proteins into large scale production.

AMSilk and 21st.BIO announce partnership to accelerate the production of advanced materials made from spider silk-based proteins

Retrieved on:

Wednesday, January 17, 2024

CO2, BIO, Mercedes-Benz, Partnership, Car, Fermentation, Gel, Water, Protein, AMSilk, Silk

NEURIED, Germany and COPENHAGEN, Denmark, Jan. 17, 2024 /PRNewswire/ -- AMSilk, a global leader in advanced materials made from spider silk-based proteins, and 21st.BIO, a leader in bioproduction, today announced that they have joined forces to accelerate the upscaling of AMSilk's silk protein production to unprecedented levels. As part of the partnership, 21st.BIO has developed a new protein production strain created from highly specialized precision fermented microorganisms, ensuring that AMSilk can meet demand as it increases production from the laboratory to industrial scale.

Key Points:

Due to its unique combination of strength and flexibility, spider silk is the gold standard of bio industrial materials.
With a strong patent portfolio, AMSilk is leading the discovery of performance materials based on spider silk proteins.
Gudrun Vogtentanz, Chief Scientific Officer, AMSilk said: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
With spider silk proteins this has been challenging, but AMSilk is the first to be able to achieve that goal and bring spider silk proteins into large scale production.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on:

Tuesday, November 7, 2023

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points:

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on:

Tuesday, November 7, 2023

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points:

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

Global Market for Bioplastics and Natural Fibers Report 2023-2033: Profiles of 500 Companies Including BASF, NatureWorks, Cathay, DuPont and Spiber - ResearchAndMarkets.com

Retrieved on:

Thursday, November 2, 2023

The "Global Market for Bioplastics and Natural Fibers 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Global Market for Bioplastics and Natural Fibers 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The bioplastics and natural fibers market will witness good growth through to 2033, with excellent opportunities for large producers and start-ups.
The report provides an in depth analysis of the bioplastics and natural fibers market by applications and bioplastic and natural fiber type.
Analysis of natural fibers including seed fibers (cotton, luffa), bast fibers (jute, hemp, flax, ramie, kenaf), leaf fibers (sisal, abaca).

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

Retrieved on:

Tuesday, October 17, 2023

Health, National Science Advisory Board for Biosecurity, CSO, Protein engineering, R, Automotive Supplier Innovation Program, Big data, Protein, DSM (company), AMSilk, Advisory board, Research program, Management, Fine chemical

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).

Key Points:

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).
Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Gudrun's skills and experience in designing proteins and accelerating time-to-market are of significant importance for AMSilk in the current scale-up phase."
Gudrun Vogtentanz, Chief Scientific Officer of AMSilk, added: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
I am excited to join AMSilk, and look forward to making a difference in sustainability while simultaneously delivering high-performance products."